Go Back
NGN Capital
NGN Capital, a venture fund founded in 2003 by Ken Abramowitz, focuses on Pre-Seed to Series D investments in BioTech and Healthcare sectors. Based in New York, the firm has invested in 38 companies, with 13 successful exits. One of their notable portfolio companies is Exosome Diagnostics. NGN Capital actively supports innovative startups in the US and Europe, providing strategic investments to drive growth and success in the healthcare industry. For more information, visit their website: www.ngncapital.com.
About
About
About
Bio
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Ken Abramowitz
Bio
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Ken Abramowitz
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare
Number of investments
38
Number of exits
13
Fund Type
Venture Fund
Portfolio Companies
Exosome Diagnostics
NGN Capital
NGN Capital, a venture fund founded in 2003 by Ken Abramowitz, focuses on Pre-Seed to Series D investments in BioTech and Healthcare sectors. Based in New York, the firm has invested in 38 companies, with 13 successful exits. One of their notable portfolio companies is Exosome Diagnostics. NGN Capital actively supports innovative startups in the US and Europe, providing strategic investments to drive growth and success in the healthcare industry. For more information, visit their website: www.ngncapital.com.
About
Bio
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.
Location
New York
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Ken Abramowitz
Fund
Fund Focus
BioTech, Healthcare
Number of investments
38
Number of exits
13
Fund Type
Venture Fund
Portfolio Companies
Exosome Diagnostics